New drug S-740792 tested in healthy volunteers for first time
NCT ID NCT06724978
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested the safety and processing of a new drug called S-740792 in 99 healthy adults. Participants received single or multiple doses of the drug as a liquid or tablet, and some received a placebo. The goal was to gather safety data and understand how the body handles the drug, which is a necessary step before testing it in patients with a disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
S-740792 (oral suspension and tablet)
What this could lead to
If successful, this study could provide safety data needed to test S-740792 in patients with a specific disease in the future.
What could go wrong
This is a very early Phase 1 trial in healthy people, not patients. It only checks safety and how the drug moves through the body, not whether it treats any disease. Many drugs fail in later stages.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit, Inc.
Daytona Beach, Florida, 32117, United States